Veracyte (VCYT) analyst forecast and price target
Analyst forecast
Consensus of 12 analyst ratings
Based on 6 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Underweight | $44.00 from $47.00 | Aug 4, 2026 |
| Stephens & Co. | Maintained | Overweight | $55.00 from $68.00 | Aug 4, 2026 |
| Piper Sandler | Maintained | Overweight | $54.00 from $66.00 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Hold | $50.00 from $60.00 | Aug 3, 2026 |
| Needham | Maintained | Buy | $69.00 from $57.00 | Jul 31, 2026 |
| Needham | Maintained | Buy | $69.00 from $57.00 | Jul 30, 2026 |
| Piper Sandler | Initiated Coverage | Overweight | $66.00 | Jul 15, 2026 |
| Canaccord Genuity | Maintained | Hold | $60.00 from $42.00 | Jul 14, 2026 |
| Morgan Stanley | Maintained | Underweight | $47.00 from $37.00 | Jul 9, 2026 |
| Guggenheim | Maintained | Buy | $65.00 from $45.00 | Jun 29, 2026 |
| Needham | Maintained | Buy | $57.00 from $48.00 | Jun 1, 2026 |
| Needham | Maintained | Buy | $48.00 | May 28, 2026 |
| UBS | Maintained | Buy | $52.00 from $48.00 | May 6, 2026 |
| Canaccord Genuity | Maintained | Hold | $42.00 from $40.00 | May 6, 2026 |
| Canaccord Genuity | Maintained | Hold | $40.00 from $43.00 | Apr 20, 2026 |
| Jefferies | Initiated Coverage | Buy | $45.00 | Apr 13, 2026 |
| Needham | Maintained | Buy | $48.00 | Apr 1, 2026 |
| Guggenheim | Maintained | Buy | $45.00 from $50.00 | Mar 30, 2026 |
| Morgan Stanley | Maintained | Underweight | $37.00 from $48.00 | Mar 6, 2026 |
| Needham | Maintained | Buy | $48.00 from $44.00 | Feb 26, 2026 |
Frequently asked questions
What is the price target for VCYT stock?
The average 12-month analyst price target for Veracyte (VCYT) is $56.17, with a high estimate of $69.00 and a low of $44.00, across 6 analysts.
Is VCYT a buy, sell, or hold?
Analysts covering Veracyte currently average a Buy rating: 10 buy, 1 hold and 1 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for VCYT?
The average price target of $56.17 implies 31.03% upside from the last price of $42.87.
What is the latest analyst rating on VCYT?
On Aug 4, 2026, Morgan Stanley maintained Veracyte at Underweight with a price target of $44.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.